11/18/2026
South Korea's decision to grant a new patent extends Annamycin protection into another key Asia-Pacific market, reinforcing Moleculin's multi-layered patent portfolio spanning more than 20 jurisdictions as the Company's pivotal Phase 3 MIRACLE trial advances. Read more: https://bit.ly/4zPgpMn